Cancer Genetics

While cancer risk is a major concern for patients and their families, genomic discovery is ever expanding at a rapid pace.

Certain genetic variants can make some people’s risk of developing cancer significantly higher than that of the average person. Cancer is brought on by mutations in certain genes that result in abnormal and uncontrolled cell growth. What many people do not know is that is that these genes can be passed down from one generation to another, even if undetected. Genetic testing can help guide patient and healthcare professionals’ decisions about treatment or prevention plans for patients that have a personal or family history of cancer.

Our hereditary cancer screening identifies the risk of developing breast, ovarian, prostate, colon, pancreatic and uterine cancers. We provide DNA sequencing for specific panels which allows us to focus on certain areas of interest.

With Gibson Diagnostic Lab’s CGX test, we can tell if you carry multiple gene mutations that may be strong risk indicators for breast and ovarian cancer.

In addition, we can also identify your risk of developing other hereditary cancers including ovarian, colon and endometrial. The test is simple and accurate. Even if you do not have cancer, genetic testing can identify your potential hereditary risks, especially if you have a family member that has been diagnosed.

CGX is a comprehensive DNA profiling and gene analysis in determining inherited risk for cancer. The advantage lies in our multi-networked genomic knowledge base. Each patient’s test results are analyzed through this knowledge base which includes multiple national databases comprised of millions of biomedical findings that are constantly updated with new clinical research findings, population frequency data, FDA drug labels and treatment guidelines.

Turn Around Time:
2 Weeks

Gibson Diagnostic’s testing offers six Cancer Risk Panels providing medically actionable and relevant information on 40+ genes covering all related cancer types.